Navigating neuroimaging in Alzheimer’s care
Navigating neuroimaging in Alzheimer’s care
An expert-led program designed to empower you with the latest insights, practical strategies, and real-world case studies on PET imaging in Alzheimer’s disease.
Faculty Prof. Silvia Morbelli, Prof. Alexander Drzezga, Dr. Ana Franceschi, Prof. Janathan E McConathy, Prof. Hiroshi Matsuda, Dr. Tanyaluck Thientunyakit
Target audience Imaging physicians, Nuclear Medicine Physicians, Radiologists, Neuroradiologists, Radiology Physician Assistants, Imaging Residents, Neurologists.
Alzheimer’s disease in the biomarker era
This expert-led program offers educational resources to support healthcare professionals across the multidisciplinary care team to implement advances in biomarkers to improve the diagnosis and management of patients with Alzheimer’s disease.
Faculty Prof. Dorota Religa, Dr. Chuck Vega, Dr. Carolyn Clevenger, Prof. Robert Perneczky, Prof. Hitoshi Shimada
Target audience Dementia specialists, neurologists, geriatricians, geriatric psychiatrists, primary care providers, imaging physicians, advanced practice providers (NPs/PAs), and all members of the multidisciplinary team that manage patients with Alzheimer’s disease.
Next-generation CAR-T cell therapy for high-risk LBCL and R/R DLBCL
Next-generation CAR-T cell therapy for high-risk LBCL and R/R DLBCL
This program aims to provide the latest data and discussion-based insights on emerging CAR-T cell therapies for high-risk LBCL and R/R DLBCL, generating confidence for timely integration into clinical practice on approval.
Faculty Dr. Marco Davila, Dr. Anna Sureda, Dr. Sairah Ahmed, Dr. Gloria, Iacoboni, Prof. Emmanual Bachy, Dr. Jason Westin, Dr. Pim Mutsaers, Dr. Edward Cliff
Target audience Specialist and community hematologists, oncologists and the wider healthcare team involved in treating patients with CAR-T therapies. This activity is for healthcare professionals outside of the USA and UK
Enhancing outcomes in Lennox-Gastaut Syndrome
Enhancing outcomes in Lennox-Gastaut Syndrome
Through a series of six bite-sized ‘mini masterclass’ videos hosted by our expert faculty, this educational program aims to equip healthcare professionals with science-based insights into the pathophysiology, burden, and management of LGS.
Faculty Prof. Andreea Nissenkorn, Dr. Antonio Gil-Nagel Rein, Prof. Takamichi Yamamoto
Target audience Neurologists, pediatric neurologists, PCPs, advanced practice providers, and other HCPs involved in the care and management of patients with LGS.
Multidisciplinary tumor board live: HR+/HER2- early breast cancer: Predicting response to adjuvant therapy
Multidisciplinary tumor board live: HR+/HER2- early breast cancer: Predicting response to adjuvant therapy
This educational program aims to strengthen multidisciplinary competence in interpreting gene expression and recurrence risk scores alongside clinicopathological factors, with a focus on multidisciplinary decision-making to optimize adjuvant treatment strategies and personalize patient care.
Faculty Chair: Prof. Dr. med. Nadia Harbeck and Prof. Dr. med. Marc Thill Prof. Dr. Beyhan Ataseven, Dr. Steffi Busch, Dr. Elena-Diana Chiru, Prof. Dr. Diana Lüftner, Prof. Dr. Sven Perner, Prof. Dr. Michael Untch, Esther Wiedemann
Target audience Gynecologists from university hospitals and private practices, pathologists, and specialized nursing professionals in Germany and Switzerland.
Improving PSC care through expert-guided strategies
Improving PSC care through expert-guided strategies
This expert-led program delivers timely insights into the latest clinical data and emerging evidence in PSC, with expert commentary that places new findings into the context of everyday practice. Stay up to date on advances in research, evolving management strategies, and perspectives that can help guide patient care.
Faculty Dr Andreas Kremer, Dr Marlyn Mayo
Target audience Hepatologists and gastroenterologists
Improving PBC outcomes by prioritizing patients’ needs
Improving PBC outcomes by prioritizing patients’ needs
This expert-led program will allow you to effectively evaluate treatment response in your patients, and make informed decisions on individualized patient management strategies, regarding therapy response, symptom management, clinical guidelines, and new advances in the PBC treatment landscape.
Faculty Dr Kris Kowdley, Dr Andeas Kremer, Dr Marlyn Mayo
Target audience Hepatologists and gastroenterologists
